QUOTED. Oliver Bisazza.
In the EU, lack of regulatory predictability is creating frustration and sending innovators across the Atlantic. MedTech Europe director Oliver Bisazza considered the issue in a conversation with Medtech Insight.
“A significant number of companies are moving to other geographies, but what no one knows for sure yet is whether that is a permanent change or whether it's a temporary situation because of all the transitional challenges the sector is going through.” – Oliver Bisazza, director general industrial policies and external affairs, MedTech Europe
- Find out more: EU MedTech Forum 2022: Regulatory Unpredictability Spurs Renewed Calls For Devices Agency
Click here for a free trial of Medtech Insight